Clinical Trial Update: Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating rituximab and bendamustine in very elderly or medically non-fit elderly patients with aggressive B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Rituximab (rituximab)

Snippet

Sponsor: University of Göttingen | Conditions: Aggressive Lymphoma | Phase 2 | Status: COMPLETED